Drugs / Raptiva
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | Raptiva | — | 2009-06-09 | europa.eu ↗ |
| Approved | EU (EMA) | Raptiva | — | 2004-09-20 | europa.eu ↗ |
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00226057 | Jun → Nov 2005 | atopic eczema | Oregon Health and Science University | Completed | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT00672204 | Nov 2007 → Dec 2010 | hypoglycemia, type 1 diabetes mellitus | University of Minnesota | Terminated | No outcome recorded |
| Phase 1/2 | NCT00501709 | Feb 2007 → Dec 2016 | type 1 diabetes mellitus | University of California, San Francisco | Completed | No outcome recorded |
| Phase 1/2 | NCT00368654 | Jan 2007 → May 2008 | psoriasis | University of California, Davis | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00344448 | Jun 2006 → Jan 2009 | Sjogren syndrome | National Institute of Dental and Craniofacial Research (NIDCR) | Terminated | No outcome recorded |
| Phase 2 | NCT00308204 | Mar 2006 → Aug 2007 | discoid lupus erythematosus | The Cleveland Clinic | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Raptiva | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00344448 ↗ |
| Known as | efalizumab | “Raptiva (efalizumab) is a humanized immunoglobulin(a protein extract from blood which fights off infection-sometimes called "antibody")” NCT00308204 ↗ |
| Action | Inhibit | “inhibition of T cell trafficking to the skin with Raptiva” NCT00226057 ↗ |
| Modality | Protein / enzyme biologic | “Raptiva (efalizumab) is a humanized immunoglobulin(a protein extract from blood which fights off infection-sometimes called "antibody")” NCT00308204 ↗ |
| Route | Subcutaneous | “Raptiva administered by weekly subcutaneous injections.” NCT00226057 ↗ |